NIAID Banner Logo Image

HIV Citation List: July 6 - July 19, 2012

PubMed citations

1. An Efficient Synthesis of a Hydroxyethylamine (HEA) Isostere and Its Alpha-aminophosphonate and Phosphoramidate Derivatives as Potential anti-HIV Agents. Bhattacharya, A.K., K.C. Rana, C. Pannecouque, and E. De Clercq, ChemMedChem, 2012. [Epub ahead of print]; PMID[22786810].

[PubMed]. HIV_0706-071912.

2. Ligand-free Suzuki Coupling of Arylboronic acids with Methyl (E)-4-bromobut-2-enoate: Synthesis of Unconventional Cores of HIV-1 Protease Inhibitors. Chiummiento, L., M. Funicello, P. Lupattelli, and F. Tramutola, Organic Letters, 2012. [Epub ahead of print]; PMID[22804107].

[PubMed]. HIV_0706-071912.

3. Fragment Hopping Approach Directed at Design of HIV IN-LEDGF/p75 Interaction Inhibitors. De Luca, L., S. Ferro, F. Morreale, F. Christ, Z. Debyser, A. Chimirri, and R. Gitto, Journal of Enzyme Inhibition and Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22803661].

[PubMed]. HIV_0706-071912.

4. Carbonylhydrazide-based Molecular Tongs Inhibit Wild-type and Mutated HIV-1 Protease Dimerization. Dufau, L., A.S. Marques Ressurreicao, R. Fanelli, N. Kihal, A. Vidu, T. Milcent, J.L. Soulier, J. Rodrigo De Losada, A. Desvergne, K. Leblanc, G. Bernadat, B. Crousse, M. Reboud-Ravaux, and S. Ongeri, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22800535].

[PubMed]. HIV_0706-071912.

5. NX43Inhibition of XMRV and HIV-1 Proteases by Pepstatin a and Acetyl-pepstatin. Matuz, K., J. Motyan, M. Li, A. Wlodawer, and J. Tozser, FEBS Journal, 2012. [Epub ahead of print]; PMID[22804908].

[PubMed]. HIV_0706-071912.

6. Use of ATP Analogs to Inhibit HIV-1 Transcription. Narayanan, A., G. Sampey, R. Van Duyne, I. Guendel, K. Kehn-Hall, J. Roman, R. Currer, H. Galons, N. Oumata, B. Joseph, L. Meijer, M. Caputi, S. Nekhai, and F. Kashanchi, Virology, 2012. [Epub ahead of print]; PMID[22771113].

[PubMed]. HIV_0706-071912.

7. Design, Synthesis, and Biological and Structural Evaluations of Novel HIV-1 Protease Inhibitors to Combat Drug Resistance. Parai, M.K., D.J. Huggins, H. Cao, M.N. Nalam, A. Ali, C.A. Schiffer, B. Tidor, and T.M. Rana, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22708897].

[PubMed]. HIV_0706-071912.

8. Small Molecule Inhibitors of the LEDGF Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design. Peat, T.S., D.I. Rhodes, N. Vandegraaff, G. Le, J.A. Smith, L.J. Clark, E.D. Jones, J.A. Coates, N. Thienthong, J. Newman, O. Dolezal, R. Mulder, J.H. Ryan, G.P. Savage, C.L. Francis, and J.J. Deadman, PLoS One, 2012. 7(7): p. e40147; PMID[22808106].

[PubMed]. HIV_0706-071912.

ISI Web of Knowledge Citations

9. Synthesis and Structure-Activity Relationship Studies of HIV-1 Virion Infectivity Factor (vif) Inhibitors That Block Viral Replication. Ali, A., J.H. Wang, R.S. Nathans, H. Cao, N. Sharova, M. Stevenson, and T.M. Rana, ChemMedChem, 2012. 7(7): p. 1217-1229; ISI[000305604100010].

[WOS]. HIV_0706-071912.

10. Amino Acid Derivatives of the (-) Enantiomer of Gossypol Are Effective Fusion Inhibitors of Human Immunodeficiency Virus Type 1. An, T., W.J. Ouyang, W. Pan, D.Y. Guo, J.R. Li, L.L. Li, G. Chen, J. Yang, S.W. Wu, and P. Tien, Antiviral Research, 2012. 94(3): p. 276-287; ISI[000305202300009].

[WOS]. HIV_0706-071912.

11. Identification of HIV-1 Inhibitors Targeting the Nucleocapsid Protein. Breuer, S., M.W. Chang, J.Y. Yuan, and B.E. Torbett, Journal of Medicinal Chemistry, 2012. 55(11): p. 4968-4977; ISI[000305356400006].

[WOS]. HIV_0706-071912.

12. Design, Synthesis, and X-ray Crystallographic Analysis of a Novel Class of HIV-1 Protease Inhibitors. Ganguly, A.K., S.S. Alluri, D. Caroccia, D. Biswas, C.H. Wang, E.H. Kang, Y. Zhang, A.T. McPhail, S.S. Carroll, C. Burlein, V. Munshi, P. Orth, and C. Strickland, Journal of Medicinal Chemistry, 2012. 55(11): p. 5647-5647; ISI[000305356400062].

[WOS]. HIV_0706-071912.

13. Vaginal Film Drug Delivery of the Pyrimidinedione IQP-0528 for the Prevention of HIV Infection. Ham, A.S., L.C. Rohan, A. Boczar, L. Yang, K.W. Buckheit, and R.W. Buckheit, Pharmaceutical Research, 2012. 29(7): p. 1897-1907; ISI[000305222000017].

[WOS]. HIV_0706-071912.

14. Design, Synthesis and Evaluation of Unique 2,4,5-triaryl Imidazole Derivatives as Novel Potent Aspartic Protease Inhibitors. Khan, M.S., S. Akhtar, S.A. Siddiqui, M.S. Siddiqui, K.V. Srinivasan, and J.M. Arif, Medicinal Chemistry, 2012. 8(3): p. 428-435; ISI[000305295000014].

[WOS]. HIV_0706-071912.

15. Distinct Effects of Two HIV-1 Capsid Assembly Inhibitor Families That Bind the Same Site within the N-terminal Domain of the Viral CA Protein. Lemke, C.T., S. Titolo, U. von Schwedler, N. Goudreau, J.F. Mercier, E. Wardrop, A.M. Faucher, R. Coulombe, S.S.R. Banik, L. Fader, A. Gagnon, S.H. Kawai, J. Rancourt, M. Tremblay, C. Yoakim, B. Simoneau, J. Archambault, W.I. Sundquist, and S.W. Mason, Journal of Virology, 2012. 86(12): p. 6643-6655; ISI[000304894100025].

[WOS]. HIV_0706-071912.

16. Isolation and Identification of a Novel Polysaccharide-peptide Complex with Antioxidant, Anti-proliferative and Hypoglycaemic Activities from the Abalone Mushroom. Li, N., L. Li, J.C. Fang, J.H. Wong, T.B. Ng, Y. Jiang, C.R. Wang, N.Y. Zhang, T.Y. Wen, L.Y. Qu, P.Y. Lv, R.L. Zhao, B. Shi, Y.P. Wang, X.Y. Wang, and F. Liu, Bioscience Reports, 2012. 32(3): p. 221-228; ISI[000304892700002].

[WOS]. HIV_0706-071912.

17. Intravaginal Ring Delivery of Tenofovir Disoproxil Fumarate for Prevention of HIV and Herpes Simplex Virus Infection. Mesquita, P.M.M., R. Rastogi, T.J. Segarra, R.S. Teller, N.M. Torres, A.M. Huber, P.F. Kiser, and B.C. Herold, Journal of Antimicrobial Chemotherapy, 2012. 67(7): p. 1730-1738; ISI[000305086600025].

[WOS]. HIV_0706-071912.

18. Characterization of a Peptide Domain within the GB Virus C Envelope Glycoprotein (E2) That Inhibits HIV Replication. Xiang, J.H., J.H. McLinden, T.M. Kaufman, E.L. Mohr, N. Bhattarai, Q. Chang, and J.T. Stapleton, Virology, 2012. 430(1): p. 53-62; ISI[000305381000006].

[WOS]. HIV_0706-071912.

Latent HIV Reactivation

19. BET Bromodomain Inhibition as a Novel Strategy for Reactivation of HIV-1. Banerjee, C., N. Archin, D. Michaels, A.C. Belkina, G.V. Denis, J. Bradner, P. Sebastiani, D.M. Margolis, and M. Montano, Journal of Leukocyte Biology, 2012. [Epub ahead of print]; PMID[22802445].

[PubMed]. HIV_0706-071912.

Animal Studies

20. Prolonged Tenofovir Treatment of Macaques Infected with K65R Reverse Transcriptase Mutants of SIV Results in the Development of Antiviral Immune Responses That Control Virus Replication after Drug Withdrawal. Van Rompay, K.K., K.A. Trott, K. Jayashankar, Y. Geng, C.C. Labranche, J.A. Johnson, G. Landucci, J. Lipscomb, R.P. Tarara, D.R. Canfield, W. Heneine, D.N. Forthal, D. Montefiori, and K. Abel, Retrovirology, 2012. 9(1): p. 57; PMID[22805180].

[PubMed]. HIV_0706-071912.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022